Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Lawrence Edwards

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
The Journal of Rheumatology|June 7, 2007
Outcome evaluations in goutH Ralph Schumacher, William Taylor, Nancy Joseph-Ridge, et al.
Current Rheumatology Reports|February 15, 2022
Expert Opinion on Pegloticase with Concomitant Immunomodulatory Therapy in the Treatment of Uncontrolled Gout to Improve Efficacy, Safety, and Durability of ResponseJohn K Botson, Herbert S B Baraf, Robert T Keenan, et al.
The Journal of Rheumatology|January 17, 2014
Application of the OMERACT filter to measures of core outcome domains in recent clinical studies of acute goutWilliam J Taylor, David Redden, Nicola Dalbeth, et al.
The Journal of Rheumatology|October 13, 2009
Progress in measurement instruments for acute and chronic gout studiesRebecca Grainger, William J Taylor, Nicola Dalbeth, et al.
The Journal of Rheumatology|July 5, 2011
Tophus measurement as an outcome measure for clinical trials of chronic gout: progress and research prioritiesNicola Dalbeth, Fiona M McQueen, Jasvinder A Singh, et al.
The Journal of Rheumatology|July 5, 2011
Bringing it all together: a novel approach to the development of response criteria for chronic gout clinical trialsWilliam J Taylor, Jasvinder A Singh, Kenneth G Saag, et al.
Seminars in Arthritis and Rheumatism|March 24, 2023
Outcome reporting in randomized trials in gout: A systematic scoping review from the OMERACT gout working group assessing the uptake of the core outcome setMelanie B Morillon, Alexander Nørup, Jasvinder A Singh, et al.
The Journal of Rheumatology|December 17, 2013
OMERACT endorsement of measures of outcome for studies of acute goutJasvinder A Singh, William J Taylor, Nicola Dalbeth, et al.
The Journal of Rheumatology|July 5, 2011
Serum urate in chronic gout--will it be the first validated soluble biomarker in rheumatology?Lisa K Stamp, Puja P Khanna, Nicola Dalbeth, et al.
JAMA|August 18, 2011
Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trialsJohn S Sundy, Herbert S B Baraf, Robert A Yood, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
The Journal of Rheumatology|June 7, 2007
Outcome evaluations in goutH Ralph Schumacher, William Taylor, Nancy Joseph-Ridge, et al.
Current Rheumatology Reports|February 15, 2022
Expert Opinion on Pegloticase with Concomitant Immunomodulatory Therapy in the Treatment of Uncontrolled Gout to Improve Efficacy, Safety, and Durability of ResponseJohn K Botson, Herbert S B Baraf, Robert T Keenan, et al.
The Journal of Rheumatology|January 17, 2014
Application of the OMERACT filter to measures of core outcome domains in recent clinical studies of acute goutWilliam J Taylor, David Redden, Nicola Dalbeth, et al.
The Journal of Rheumatology|October 13, 2009
Progress in measurement instruments for acute and chronic gout studiesRebecca Grainger, William J Taylor, Nicola Dalbeth, et al.
The Journal of Rheumatology|July 5, 2011
Tophus measurement as an outcome measure for clinical trials of chronic gout: progress and research prioritiesNicola Dalbeth, Fiona M McQueen, Jasvinder A Singh, et al.
The Journal of Rheumatology|July 5, 2011
Bringing it all together: a novel approach to the development of response criteria for chronic gout clinical trialsWilliam J Taylor, Jasvinder A Singh, Kenneth G Saag, et al.
Seminars in Arthritis and Rheumatism|March 24, 2023
Outcome reporting in randomized trials in gout: A systematic scoping review from the OMERACT gout working group assessing the uptake of the core outcome setMelanie B Morillon, Alexander Nørup, Jasvinder A Singh, et al.
The Journal of Rheumatology|December 17, 2013
OMERACT endorsement of measures of outcome for studies of acute goutJasvinder A Singh, William J Taylor, Nicola Dalbeth, et al.
The Journal of Rheumatology|July 5, 2011
Serum urate in chronic gout--will it be the first validated soluble biomarker in rheumatology?Lisa K Stamp, Puja P Khanna, Nicola Dalbeth, et al.
JAMA|August 18, 2011
Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trialsJohn S Sundy, Herbert S B Baraf, Robert A Yood, et al.
Pageof 7